Evidence-Based Benefits
- Immune enhancement — a 2013 meta-analysis (Defined Health) of 34 RCTs found astragalus-based formulas significantly improved immune parameters (T-cell counts, NK cell activity) in cancer patients receiving chemotherapy
- Cardiovascular protection — Luo et al. (2015) reviewed clinical evidence showing astragaloside IV protects against heart failure by reducing oxidative stress and improving cardiac function
- Telomere support — cycloastragenol (TA-65) activates telomerase, and Harley et al. (2011) showed it improved immune cell telomere length in a pilot human study
- Kidney protection — astragalus polysaccharides have been shown to reduce proteinuria and improve kidney function markers in diabetic nephropathy patients (Li et al., 2011 meta-analysis)
- Anti-inflammatory — astragalosides inhibit NF-κB and reduce TNF-α, IL-1β, and IL-6 production